115 related articles for article (PubMed ID: 12814959)
1. Protein covalent binding of maxipost through a cytochrome P450-mediated ortho-quinone methide intermediate in rats.
Zhang D; Ogan M; Gedamke R; Roongta V; Dai R; Zhu M; Rinehart JK; Klunk L; Mitroka J
Drug Metab Dispos; 2003 Jul; 31(7):837-45. PubMed ID: 12814959
[TBL] [Abstract][Full Text] [Related]
2. Metabolism, pharmacokinetics, and protein covalent binding of radiolabeled MaxiPost (BMS-204352) in humans.
Zhang D; Krishna R; Wang L; Zeng J; Mitroka J; Dai R; Narasimhan N; Reeves RA; Srinivas NR; Klunk LJ
Drug Metab Dispos; 2005 Jan; 33(1):83-93. PubMed ID: 15502007
[TBL] [Abstract][Full Text] [Related]
3. NADPH-dependent covalent binding of [3H]paroxetine to human liver microsomes and S-9 fractions: identification of an electrophilic quinone metabolite of paroxetine.
Zhao SX; Dalvie DK; Kelly JM; Soglia JR; Frederick KS; Smith EB; Obach RS; Kalgutkar AS
Chem Res Toxicol; 2007 Nov; 20(11):1649-57. PubMed ID: 17907785
[TBL] [Abstract][Full Text] [Related]
4. Amide N-glucuronidation of MaxiPost catalyzed by UDP-glucuronosyltransferase 2B7 in humans.
Zhang D; Zhao W; Roongta VA; Mitroka JG; Klunk LJ; Zhu M
Drug Metab Dispos; 2004 May; 32(5):545-51. PubMed ID: 15100177
[TBL] [Abstract][Full Text] [Related]
5. Bioactivation of phenytoin by human cytochrome P450: characterization of the mechanism and targets of covalent adduct formation.
Munns AJ; De Voss JJ; Hooper WD; Dickinson RG; Gillam EM
Chem Res Toxicol; 1997 Sep; 10(9):1049-58. PubMed ID: 9305589
[TBL] [Abstract][Full Text] [Related]
6. Bioactivation of isothiazoles: minimizing the risk of potential toxicity in drug discovery.
Teffera Y; Choquette D; Liu J; Colletti AE; Hollis LS; Lin MH; Zhao Z
Chem Res Toxicol; 2010 Nov; 23(11):1743-52. PubMed ID: 20825217
[TBL] [Abstract][Full Text] [Related]
7. Mechanism-based inactivation of hepatic ethoxyresorufin O-dealkylation activity by naturally occurring coumarins.
Cai Y; Baer-Dubowska W; Ashwood-Smith MJ; Ceska O; Tachibana S; DiGiovanni J
Chem Res Toxicol; 1996 Jun; 9(4):729-36. PubMed ID: 8831817
[TBL] [Abstract][Full Text] [Related]
8. Bioactivation of 4-methylphenol (p-cresol) via cytochrome P450-mediated aromatic oxidation in human liver microsomes.
Yan Z; Zhong HM; Maher N; Torres R; Leo GC; Caldwell GW; Huebert N
Drug Metab Dispos; 2005 Dec; 33(12):1867-76. PubMed ID: 16174805
[TBL] [Abstract][Full Text] [Related]
9. Characterization of HKI-272 covalent binding to human serum albumin.
Wang J; Li-Chan XX; Atherton J; Deng L; Espina R; Yu L; Horwatt P; Ross S; Lockhead S; Ahmad S; Chandrasekaran A; Oganesian A; Scatina J; Mutlib A; Talaat R
Drug Metab Dispos; 2010 Jul; 38(7):1083-93. PubMed ID: 20400660
[TBL] [Abstract][Full Text] [Related]
10. Metabolic activation of troglitazone: identification of a reactive metabolite and mechanisms involved.
He K; Talaat RE; Pool WF; Reily MD; Reed JE; Bridges AJ; Woolf TF
Drug Metab Dispos; 2004 Jun; 32(6):639-46. PubMed ID: 15155556
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of 3-methylindole by vaccinia-expressed P450 enzymes: correlation of 3-methyleneindolenine formation and protein-binding.
Thornton-Manning J; Appleton ML; Gonzalez FJ; Yost GS
J Pharmacol Exp Ther; 1996 Jan; 276(1):21-9. PubMed ID: 8558432
[TBL] [Abstract][Full Text] [Related]
12. Differences in the pharmacokinetics of peroxisome proliferator-activated receptor agonists in genetically obese Zucker and sprague-dawley rats: implications of decreased glucuronidation in obese Zucker rats.
Kim MS; Wang S; Shen Z; Kochansky CJ; Strauss JR; Franklin RB; Vincent SH
Drug Metab Dispos; 2004 Sep; 32(9):909-14. PubMed ID: 15319330
[TBL] [Abstract][Full Text] [Related]
13. Effect of dose and input rate on the brain penetration of BMS-204352 following intravenous administration to rats.
Krishna R; Palme H; Zeng J; Srinivas N
Biopharm Drug Dispos; 2002 Sep; 23(6):227-31. PubMed ID: 12214322
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P450 11A1 bioactivation of a kinase inhibitor in rats: use of radioprofiling, modulation of metabolism, and adrenocortical cell lines to evaluate adrenal toxicity.
Zhang D; Flint O; Wang L; Gupta A; Westhouse RA; Zhao W; Raghavan N; Caceres-Cortes J; Marathe P; Shen G; Zhang Y; Allentoff A; Josephs J; Gan J; Borzilleri R; Humphreys WG
Chem Res Toxicol; 2012 Mar; 25(3):556-71. PubMed ID: 22295996
[TBL] [Abstract][Full Text] [Related]
15. Catalyzation of cocaine N-demethylation by cytochromes P4502B, P4503A, and P4502D in fish liver.
Arinç E; Bozcaarmutlu A
J Biochem Mol Toxicol; 2003; 17(3):169-76. PubMed ID: 12815613
[TBL] [Abstract][Full Text] [Related]
16. Bioactivation of 2,3-diaminopyridine-containing bradykinin B1 receptor antagonists: irreversible binding to liver microsomal proteins and formation of glutathione conjugates.
Tang C; Subramanian R; Kuo Y; Krymgold S; Lu P; Kuduk SD; Ng C; Feng DM; Elmore C; Soli E; Ho J; Bock MG; Baillie TA; Prueksaritanont T
Chem Res Toxicol; 2005 Jun; 18(6):934-45. PubMed ID: 15962928
[TBL] [Abstract][Full Text] [Related]
17. A novel bioactivation pathway for 2-[2-(2,6-dichlorophenyl)aminophenyl]ethanoic acid (diclofenac) initiated by cytochrome P450-mediated oxidative decarboxylation.
Grillo MP; Ma J; Teffera Y; Waldon DJ
Drug Metab Dispos; 2008 Sep; 36(9):1740-4. PubMed ID: 18541695
[TBL] [Abstract][Full Text] [Related]
18. Bioactivation of 6,7-dimethyl-2,4-di-1-pyrrolidinyl-7H-pyrrolo[2,3-d]pyrimidine (U-89843) to reactive intermediates that bind covalently to macromolecules and produce genotoxicity.
Zhao Z; Koeplinger KA; Padbury GE; Hauer MJ; Bundy GL; Banitt LS; Schwartz TM; Zimmermann DC; Harbach PR; Mayo JK; Aaron CS
Chem Res Toxicol; 1996 Dec; 9(8):1230-9. PubMed ID: 8951224
[TBL] [Abstract][Full Text] [Related]
19. Bioactivation of coumarin in rat olfactory mucosal microsomes: Detection of protein covalent binding and identification of reactive intermediates through analysis of glutathione adducts.
Zhuo X; Zhao W; Zheng J; Humphreys WG; Shu YZ; Zhu M
Chem Biol Interact; 2009 Oct; 181(2):227-35. PubMed ID: 19576871
[TBL] [Abstract][Full Text] [Related]
20. In vitro biotransformation and genotoxicity of the drinking water disinfection byproduct bromodichloromethane: DNA binding mediated by glutathione transferase theta 1-1.
Ross MK; Pegram RA
Toxicol Appl Pharmacol; 2004 Mar; 195(2):166-81. PubMed ID: 14998683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
